关注
amir sharafkhaneh
amir sharafkhaneh
Professor of Medicine, Medical Director of AI in Health, Baylor College of Medicine
在 bcm.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Toll-like receptor 4 is a sensor for autophagy associated with innate immunity
YI Xu, C Jagannath, XD Liu, A Sharafkhaneh, KE Kolodziejska, NT Eissa
Immunity 27 (1), 135-144, 2007
10412007
Association of psychiatric disorders and sleep apnea in a large cohort
A Sharafkhaneh, N Giray, P Richardson, T Young, M Hirshkowitz
Sleep 28 (11), 1405-1411, 2005
6002005
Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort
NA Hanania, H Müllerova, NW Locantore, J Vestbo, ML Watkins, ...
American journal of respiratory and critical care medicine 183 (5), 604-611, 2011
4622011
A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial
VS Fan, JM Gaziano, R Lew, J Bourbeau, SG Adams, S Leatherman, ...
Annals of internal medicine 156 (10), 673-683, 2012
4492012
Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort
H Müllerova, DJ Maselli, N Locantore, J Vestbo, JR Hurst, JA Wedzicha, ...
Chest 147 (4), 999-1007, 2015
4032015
Airway mucus: from production to secretion
OW Williams, A Sharafkhaneh, V Kim, BF Dickey, CM Evans
American journal of respiratory cell and molecular biology 34 (5), 527-536, 2006
3642006
Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression
JA Cully, DP Graham, MA Stanley, CJ Ferguson, A Sharafkhaneh, ...
Psychosomatics 47 (4), 312-319, 2006
3632006
Prevalence, predictors and economic consequences of no-shows
P Kheirkhah, Q Feng, LM Travis, S Tavakoli-Tabasi, A Sharafkhaneh
BMC health services research 16, 1-6, 2015
3492015
Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised …
EFM Wouters, DS Postma, B Fokkens, WCJ Hop, J Prins, AF Kuipers, ...
Thorax 60 (6), 480-487, 2005
3312005
COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial
ME Kunik, C Veazey, JA Cully, J Souchek, DP Graham, D Hopko, ...
Psychological medicine 38 (3), 385-396, 2008
2812008
Pathogenesis of emphysema: from the bench to the bedside
A Sharafkhaneh, NA Hanania, V Kim
Proceedings of the American Thoracic Society 5 (4), 475-477, 2008
2692008
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology
JC Hogg, FSF Chu, WC Tan, DD Sin, SA Patel, PD Pare, FJ Martinez, ...
American journal of respiratory and critical care medicine 176 (5), 454-459, 2007
2632007
Risk indexes for exacerbations and hospitalizations due to COPD
DE Niewoehner, Y Lokhnygina, K Rice, WG Kuschner, A Sharafkhaneh, ...
Chest 131 (1), 20-28, 2007
2592007
Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications
H Qureshi, A Sharafkhaneh, NA Hanania
Therapeutic advances in chronic disease 5 (5), 212-227, 2014
2382014
Oxygen therapy in chronic obstructive pulmonary disease
V Kim, JO Benditt, RA Wise, A Sharafkhaneh
Proceedings of the American Thoracic Society 5 (4), 513-518, 2008
2172008
Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease
JH Yun, A Lamb, R Chase, D Singh, MM Parker, A Saferali, J Vestbo, ...
Journal of allergy and clinical immunology 141 (6), 2037-2047. e10, 2018
2092018
Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study
A Sharafkhaneh, JG Southard, M Goldman, T Uryniak, UJ Martin
Respiratory medicine 106 (2), 257-268, 2012
1732012
A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation
CCTWGRG Barr, EA Berkowitz, F Bigazzi, F Bode, J Bon, RP Bowler, ...
COPD: Journal of Chronic Obstructive Pulmonary Disease 9 (2), 151-159, 2012
1712012
β-Agonist Intrinsic Efficacy: Measurement and Clinical Significance
NA Hanania, A Sharafkhaneh, R Barber, BF Dickey
American journal of respiratory and critical care medicine 165 (10), 1353-1358, 2002
1372002
The asthma COPD overlap syndrome (ACOS)
S Bujarski, AD Parulekar, A Sharafkhaneh, NA Hanania
Current allergy and asthma reports 15, 1-9, 2015
1142015
系统目前无法执行此操作,请稍后再试。
文章 1–20